F. Tentori, Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS), American Journal of Kidney Diseases, vol.52, issue.3, pp.519-549, 2008.
DOI : 10.1053/j.ajkd.2008.03.020

T. E. Larsson, Conjoint Effects of Serum Calcium and Phosphate on Risk of Total, Cardiovascular, and Noncardiovascular Mortality in the Community, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.2, pp.333-342, 2010.
DOI : 10.1161/ATVBAHA.109.196675

C. M. Shanahan, Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate, Circulation Research, vol.109, issue.6, pp.697-711, 2011.
DOI : 10.1161/CIRCRESAHA.110.234914

O. Klotz, STUDIES UPON CALCAREOUS DEGENERATION: I. THE PROCESS OF PATHOLOGICAL CALCIFICATION., Journal of Experimental Medicine, vol.7, issue.6, pp.633-74, 1905.
DOI : 10.1084/jem.7.6.633

C. M. Giachelli, Vascular Calcification: In Vitro Evidence for the Role of Inorganic Phosphate, Journal of the American Society of Nephrology, vol.14, issue.90004, pp.300-304, 2003.
DOI : 10.1097/01.ASN.0000081663.52165.66

Y. Sumida, Carotid artery calcification and atherosclerosis at the initiation of hemodialysis in patients with end-stage renal disease, Clinical Nephrology, vol.73, issue.05, pp.360-369, 2009.
DOI : 10.5414/CNP73360

R. Narang, Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease, International Journal of Cardiology, vol.60, issue.1, pp.73-82, 1997.
DOI : 10.1016/S0167-5273(97)02971-9

S. Lehto, Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus, Arterioscler Thromb Vasc Biol, issue.8, pp.16-978, 1996.

L. S. Ibels, Arterial calcification and pathology in uremic patients undergoing dialysis, The American Journal of Medicine, vol.66, issue.5, pp.790-796, 1979.
DOI : 10.1016/0002-9343(79)91118-5

J. Wright and A. Hutchison, Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag, pp.713-735, 2009.

H. T. Blumenthal, A. I. Lansing, and P. A. Wheeler, Calcification of the Media of the Human Aorta and Its Relation to Intimal Arteriosclerosis, Ageing and Disease, Am J Pathol, vol.20, issue.4, pp.665-87, 1944.

Z. A. Massy, Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease, Pediatric Nephrology, vol.18, issue.3, pp.380-382, 2005.
DOI : 10.1007/s00467-004-1623-9

R. Vattikuti and D. A. Towler, Osteogenic regulation of vascular calcification: an early perspective, AJP: Endocrinology and Metabolism, vol.286, issue.5, pp.686-96, 2004.
DOI : 10.1152/ajpendo.00552.2003

Z. A. Massy, Min??ralisation anormale??: comment et pourquoi un tissu cardiovasculaire peut-il se min??raliser???, N??phrologie & Th??rapeutique, vol.9, issue.4, pp.249-52, 2006.
DOI : 10.1016/j.nephro.2013.06.002

C. M. Giachelli, Vascular calcification and inorganic phosphate, American Journal of Kidney Diseases, vol.38, issue.4, pp.34-41, 2001.
DOI : 10.1053/ajkd.2001.27394

H. Rahabi-layachi, Distinct effects of inorganic phosphate on cell cycle and apoptosis in human vascular smooth muscle cells The pathophysiology of vascular calcification: are osteoclast-like cells the missing link? Diabetes Metab, J Cell Physiol, vol.55, issue.34 1, pp.16-20, 2008.

W. L. Lau, Direct Effects of Phosphate on Vascular Cell Function, Advances in Chronic Kidney Disease, vol.18, issue.2, pp.105-117, 2011.
DOI : 10.1053/j.ackd.2010.12.002

N. X. Chen, Annexin-Mediated Matrix Vesicle Calcification in Vascular Smooth Muscle Cells, Journal of Bone and Mineral Research, vol.143, issue.11, pp.1798-805, 2008.
DOI : 10.1002/jcp.20826

J. H. Ix, Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA, Clinical Journal of the American Society of Nephrology, vol.4, issue.3, pp.609-624, 2009.
DOI : 10.2215/CJN.04100808

D. Marco and G. S. , Increased inorganic phosphate induces human endothelial cell apoptosis in vitro Effects of phosphate on vascular function under normal conditions and influence of the uraemic state, Am J Physiol Renal Physiol Cardiovasc Res, vol.294, issue.61, pp.96-130, 2008.

A. Peng, Adverse Effects of Simulated Hyper- and Hypo-Phosphatemia on Endothelial Cell Function and Viability, PLoS ONE, vol.75, issue.8, pp.23268-62, 2011.
DOI : 10.1371/journal.pone.0023268.g008

K. Kunz, Uraemic cardiomyopathy, Nephrology Dialysis Transplantation, vol.13, issue.90004, pp.39-43, 1998.
DOI : 10.1093/ndt/13.suppl_4.39

URL : http://ndt.oxfordjournals.org/cgi/content/short/13/suppl_4/39

P. S. Parfrey, Outcome and risk factors for left ventricular disorders in chronic uraemia, Nephrology Dialysis Transplantation, vol.11, issue.7, pp.1277-85, 1996.
DOI : 10.1093/ndt/11.7.1277

A. Mozar, High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells, Journal of Cellular Physiology, vol.111, issue.1, pp.47-54, 2008.
DOI : 10.1002/jcp.21283

A. Y. Rangrez, miR-143 and miR-145: Molecular Keys to Switch the Phenotype of Vascular Smooth Muscle Cells, Circulation: Cardiovascular Genetics, vol.4, issue.2, pp.197-205, 2011.
DOI : 10.1161/CIRCGENETICS.110.958702

D. Marco and G. S. , High phosphate directly affects endothelial function by downregulating annexin II, Kidney International, vol.83, issue.2, pp.213-235, 2013.
DOI : 10.1038/ki.2012.300

J. R. Dominguez, Relationships Between Serum and Urine Phosphorus With All-Cause and Cardiovascular Mortality: The Osteoporotic Fractures in Men (MrOS) Study, American Journal of Kidney Diseases, vol.61, issue.4, pp.61-555, 2013.
DOI : 10.1053/j.ajkd.2012.11.033

A. P. Mcgovern, Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study, PLoS ONE, vol.46, issue.9, p.74996, 2013.
DOI : 10.1371/journal.pone.0074996.t005

J. M. Wojcicki and R. N. Foley, Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010 Serum phosphorus levels associate with coronary atherosclerosis in young adults, BMC Nephrol J Am Soc Nephrol, vol.20, issue.72, pp.397-404, 2009.

G. Saab, Association of Serum Phosphorus With Left Ventricular Mass in Men and Women With Stable Cardiovascular Disease: Data From the Heart and Soul Study, American Journal of Kidney Diseases, vol.56, issue.3, pp.496-505, 2010.
DOI : 10.1053/j.ajkd.2010.03.030

M. Tonelli, Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease, Circulation, vol.112, issue.17, pp.2627-2660, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.553198

M. Chonchol, Serum Phosphorus and Cardiovascular Mortality in Type 2 Diabetes, The American Journal of Medicine, vol.122, issue.4, pp.380-386, 2009.
DOI : 10.1016/j.amjmed.2008.09.039

E. Grethen, Vitamin D and Hyperparathyroidism in Obesity, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.5, pp.1320-1326, 2011.
DOI : 10.1210/jc.2010-2202

A. Alonso, Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multiethnic study of atherosclerosis, Hypertension, issue.3, pp.55-776, 2010.

H. Jin, High Dietary Inorganic Phosphate Increases Lung Tumorigenesis and Alters Akt Signaling, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.1, pp.59-68, 2009.
DOI : 10.1164/rccm.200802-306OC

M. S. Calvo and K. L. Tucker, Is phosphorus intake that exceeds dietary requirements a risk factor in bone health?, Annals of the New York Academy of Sciences, vol.52, issue.Suppl., pp.29-35, 1301.
DOI : 10.1111/nyas.12300

C. M. Sullivan, J. B. Leon, and A. R. Sehgal, Phosphorus-Containing Food Additives and the Accuracy of Nutrient Databases: Implications for Renal Patients, Journal of Renal Nutrition, vol.17, issue.5, pp.350-354, 2007.
DOI : 10.1053/j.jrn.2007.05.008

R. A. Sherman and O. Mehta, Dietary Phosphorus Restriction in Dialysis Patients: Potential Impact of Processed Meat, Poultry, and Fish Products as Protein Sources, American Journal of Kidney Diseases, vol.54, issue.1, pp.18-23, 2009.
DOI : 10.1053/j.ajkd.2009.01.269

R. A. Sherman and O. Mehta, Phosphorus and Potassium Content of Enhanced Meat and Poultry Products: Implications for Patients Who Receive Dialysis, Clinical Journal of the American Society of Nephrology, vol.4, issue.8, pp.1370-1373, 2009.
DOI : 10.2215/CJN.02830409

K. Kalantar-zadeh, Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.5, issue.3, pp.519-549, 2010.
DOI : 10.2215/CJN.06080809

E. Ritz, Phosphate additives in food--a health risk, Dtsch Arztebl Int, vol.109, issue.4, p.86, 2010.

T. B. Drueke and Z. A. Massy, Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression Intestinal absorption of aluminium in renal failure, Kidney Int Nephrol Dial Transplant, vol.83, issue.17 2, pp.13-18, 2002.

A. A. Lopes, Phosphate Binder Use and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of Possible Confounding by Nutritional Status, American Journal of Kidney Diseases, vol.60, issue.1, pp.90-101, 2012.
DOI : 10.1053/j.ajkd.2011.12.025

J. B. Cannata-andia, Use of phosphate-binding agents is associated with a lower risk of mortality, Kidney International, vol.84, issue.5, pp.998-1008, 2013.
DOI : 10.1038/ki.2013.185

S. A. Jamal, Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis, The Lancet, vol.382, issue.9900, pp.382-1268, 2013.
DOI : 10.1016/S0140-6736(13)60897-1

G. A. Block, Effects of Phosphate Binders in Moderate CKD, Journal of the American Society of Nephrology, vol.23, issue.8, pp.1407-1422, 2012.
DOI : 10.1681/ASN.2012030223

A. L. Cancela, Fibroblast Growth Factor 23 in Hemodialysis Patients: Effects of Phosphate Binder, Calcitriol and Calcium Concentration in the Dialysate, Nephron Clinical Practice, vol.117, issue.1, pp.74-82, 2011.
DOI : 10.1159/000319650

S. J. Allison, Chronic kidney disease: Calcium-based versus non-calcium-based phosphate binders: effect on mortality in patients with CKD, Nature Reviews Nephrology, vol.9, issue.9, p.491, 2013.
DOI : 10.1093/ndt/gfp350

F. Yousaf and C. Charytan, Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism, Renal Failure, vol.5, issue.12, pp.131-139, 2014.
DOI : 10.1053/j.ajkd.2010.07.012

E. Zitt, Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction, Clinical Kidney Journal, vol.6, issue.3, pp.287-294, 2013.
DOI : 10.1093/ckj/sft026

A. Lenglet, Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients, Drugs in R&D, vol.24, issue.Suppl 1, pp.165-73, 2013.
DOI : 10.1007/s40268-013-0024-6

R. P. Wuthrich, Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients, Clinical Journal of the American Society of Nephrology, vol.8, issue.2, pp.280-289, 2013.
DOI : 10.2215/CJN.08230811

J. R. Wu-wong and M. Mizobuchi, Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease?, Expert Opinion on Investigational Drugs, vol.29, issue.5, pp.23-1465, 2014.
DOI : 10.2215/CJN.05170513

F. Locatelli, N. Dimkovic, and G. Spasovski, Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial, Nephrology Dialysis Transplantation, vol.28, issue.7, pp.28-1874, 2013.
DOI : 10.1093/ndt/gft064

T. Akizawa, Randomized Controlled Trial of Bixalomer Versus Sevelamer Hydrochloride in Hemodialysis Patients With Hyperphosphatemia, Therapeutic Apheresis and Dialysis, vol.67, issue.Suppl 90, pp.122-153, 2014.
DOI : 10.1111/1744-9987.12068

G. A. Block, Effect of Salivary Phosphate-Binding Chewing Gum on Serum Phosphate in Chronic Kidney Disease, Nephron Clinical Practice, vol.123, issue.1-2, pp.93-101, 2013.
DOI : 10.1159/000351850

N. Koh, Severely Reduced Production of Klotho in Human Chronic Renal Failure Kidney, Biochemical and Biophysical Research Communications, vol.280, issue.4, pp.1015-1035, 2001.
DOI : 10.1006/bbrc.2000.4226

H. Olauson, New Insights Into the FGF23-Klotho Axis, Seminars in Nephrology, vol.34, issue.6, pp.586-97, 2014.
DOI : 10.1016/j.semnephrol.2014.09.005